SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J_F_Shepard who wrote (890997)10/1/2015 6:10:46 PM
From: TimF  Read Replies (2) of 1575178
 
Its not a matter of what AstraZeneca does but what the other companies do. If any company could produce esomeprazole, as soon as they could ramp up production then there would be more likely to be competition which would erode the pricing power that AstraZeneca currently enjoys. Often this happens anyway when popular drugs go generic, but it would happen more reliably without the time and money needed for approval.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News